New CEO Sets Rx for MDC Diagnostics

Minneapolis / St. Paul Business Journal by Katharine Grayson, Staff reporter

Gregg Lehman stepped into the role of top executive at Angeion Corp. less than 24 hours after the departure of CEO Phil Smith, who spent only about four months on the job.

Immediately, a shareholder asked Lehman for his plan to turn around the medical-device maker, whose stock price had plummeted in recent years. Lehman didn’t have one ready to offer at the time, but he’s confident he has a solid one now.

Lehman, who took over last year, aims to rebuild the business with a mix of new products, acquisitions and international growth. The Vadnais Heights-based company, which makes ...